<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1383" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1383/" /><meta name="ncbi_pagename" content="Noonan Syndrome with Multiple Lentigines - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Noonan Syndrome with Multiple Lentigines - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Noonan Syndrome with Multiple Lentigines" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/05/14" /><meta name="citation_author" content="Bruce D Gelb" /><meta name="citation_author" content="Marco Tartaglia" /><meta name="citation_pmid" content="20301557" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1383/" /><meta name="citation_keywords" content="LEOPARD Syndrome" /><meta name="citation_keywords" content="Multiple Lentigines Syndrome" /><meta name="citation_keywords" content="Multiple Lentigines Syndrome" /><meta name="citation_keywords" content="LEOPARD Syndrome" /><meta name="citation_keywords" content="Dual specificity mitogen-activated protein kinase kinase 1" /><meta name="citation_keywords" content="RAF proto-oncogene serine/threonine-protein kinase" /><meta name="citation_keywords" content="Serine/threonine-protein kinase B-raf" /><meta name="citation_keywords" content="Tyrosine-protein phosphatase non-receptor type 11" /><meta name="citation_keywords" content="BRAF" /><meta name="citation_keywords" content="MAP2K1" /><meta name="citation_keywords" content="PTPN11" /><meta name="citation_keywords" content="RAF1" /><meta name="citation_keywords" content="Noonan Syndrome with Multiple Lentigines" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Noonan Syndrome with Multiple Lentigines" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Bruce D Gelb" /><meta name="DC.Contributor" content="Marco Tartaglia" /><meta name="DC.Date" content="2015/05/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1383/" /><meta name="description" content="Noonan syndrome with multiple lentigines (NSML) is a condition in which the cardinal features consist of lentigines, hypertrophic cardiomyopathy, short stature, pectus deformity, and dysmorphic facial features, including widely spaced eyes and ptosis. Multiple lentigines present as dispersed flat, black-brown macules, mostly on the face, neck and upper part of the trunk with sparing of the mucosa. In general, lentigines do not appear until age four to five years but then increase to the thousands by puberty. Some individuals with NSML do not exhibit lentigines. Approximately 85% of affected individuals have heart defects, including hypertrophic cardiomyopathy (HCM) (typically appearing during infancy and sometimes progressive) and pulmonary valve stenosis. Postnatal growth retardation resulting in short stature occurs in fewer than 50% of affected persons, although most affected individuals have a height that is less than the 25th percentile for age. Sensorineural hearing deficits, present in approximately 20%, are poorly characterized. Intellectual disability, typically mild, is observed in approximately 30% of persons with NSML." /><meta name="og:title" content="Noonan Syndrome with Multiple Lentigines" /><meta name="og:type" content="book" /><meta name="og:description" content="Noonan syndrome with multiple lentigines (NSML) is a condition in which the cardinal features consist of lentigines, hypertrophic cardiomyopathy, short stature, pectus deformity, and dysmorphic facial features, including widely spaced eyes and ptosis. Multiple lentigines present as dispersed flat, black-brown macules, mostly on the face, neck and upper part of the trunk with sparing of the mucosa. In general, lentigines do not appear until age four to five years but then increase to the thousands by puberty. Some individuals with NSML do not exhibit lentigines. Approximately 85% of affected individuals have heart defects, including hypertrophic cardiomyopathy (HCM) (typically appearing during infancy and sometimes progressive) and pulmonary valve stenosis. Postnatal growth retardation resulting in short stature occurs in fewer than 50% of affected persons, although most affected individuals have a height that is less than the 25th percentile for age. Sensorineural hearing deficits, present in approximately 20%, are poorly characterized. Intellectual disability, typically mild, is observed in approximately 30% of persons with NSML." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1383/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/leopard/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1383/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D428CDFC8C20100000000022100F7.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1383_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1383_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/noonan/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/leigh-nucl-ov/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1383_"><span class="title" itemprop="name">Noonan Syndrome with Multiple Lentigines</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: LEOPARD Syndrome, Multiple Lentigines Syndrome</div><p class="contrib-group"><span itemprop="author">Bruce D Gelb</span>, MD and <span itemprop="author">Marco Tartaglia</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1383_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1383_ai__"><div class="contrib half_rhythm"><span itemprop="author">Bruce D Gelb</span>, MD<div class="affiliation small">Departments of Pediatrics and Genetics and Genomic Sciences<br />Mindich Child Health and Development Institute<br />Icahn School of Medicine at Mount Sinai<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mssm@bleg.ecurb" class="oemail">ude.mssm@bleg.ecurb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Marco Tartaglia</span>, PhD<div class="affiliation small">Dipartimento di Ematologia, Oncologia e Medicina Molecolare<br />Istituto Superiore di Sanit&#x000e0;<br />Rome, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@ailgatrat.ocram" class="oemail">ti.ssi@ailgatrat.ocram</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 30, 2007</span>; Last Update: <span itemprop="dateModified">May 14, 2015</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="leopard.Summary" itemprop="description"><h2 id="_leopard_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Noonan syndrome with multiple lentigines (NSML) is a condition in which the cardinal features consist of lentigines, hypertrophic cardiomyopathy, short stature, pectus deformity, and <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, including widely spaced eyes and ptosis. Multiple lentigines present as dispersed flat, black-brown macules, mostly on the face, neck and upper part of the trunk with sparing of the mucosa. In general, lentigines do not appear until age four to five years but then increase to the thousands by puberty. Some individuals with NSML do not exhibit lentigines. Approximately 85% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have heart defects, including hypertrophic cardiomyopathy (HCM) (typically appearing during infancy and sometimes progressive) and pulmonary valve stenosis. Postnatal growth retardation resulting in short stature occurs in fewer than 50% of affected persons, although most affected individuals have a height that is less than the 25<sup>th</sup> percentile for age. Sensorineural hearing deficits, present in approximately 20%, are poorly characterized. Intellectual disability, typically mild, is observed in approximately 30% of persons with NSML.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of NSML is established either by clinical findings or, if clinical findings are insufficient, by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of four genes (<i>PTPN11</i>, <i>RAF1</i>, <i>BRAF</i>, and <i>MAP2K1</i>) by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. At least one additional <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is causative is likely to exist.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Treatment of cardiovascular anomalies and cryptorchidism is the same as in the general population. Treatment of hearing loss includes hearing aids, enrollment in an educational program for the hearing impaired, and consideration of cochlear implantation. Developmental disability is managed by early intervention programs and individualized education strategies.</p><p><i>Prevention of secondary complications:</i> For individuals with hypertrophic cardiomyopathy, certain physical activities may be curtailed in order to reduce the risk of sudden cardiac death.</p><p><i>Surveillance</i>: Periodic follow up and often lifelong monitoring may be necessary for any abnormality, especially a cardiovascular abnormality. For hearing loss, twice-yearly examination by a physician familiar with hereditary hearing impairment and repeat audiometry to confirm the stability of the hearing loss are recommended. Routine monitoring of developmental progress and linear growth in childhood and adolescence.</p><p><i>Agents/circumstances to avoid:</i> For individuals with hypertrophic cardiomyopathy, treatment with growth hormone must be undertaken with great caution, if at all, to avoid exacerbating a cardiac condition.</p><p><i>Pregnancy management:</i> Affected women with hypertrophic cardiomyopathy or valve dysfunction may be at risk for development or exacerbation of heart failure during pregnancy; cardiac status in these women should be monitored, especially during the second and third trimesters of pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>NSML is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with NSML may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; the proportion of cases caused by <i>de novo</i> pathogenic variants is unknown. Each child of an individual with NSML has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member is known.</p></div></div><div id="leopard.Diagnosis"><h2 id="_leopard_Diagnosis_">Diagnosis</h2><div id="leopard.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Noonan syndrome with multiple lentigines (NSML) <b>should be suspected</b> in individuals with one or more of the following cardinal features:</p><ul><li class="half_rhythm"><div>Lentigines</div></li><li class="half_rhythm"><div>Cardiac abnormalities, particularly hypertrophic cardiomyopathy</div></li><li class="half_rhythm"><div>Poor linear growth/short stature</div></li><li class="half_rhythm"><div>Pectus deformity</div></li><li class="half_rhythm"><div>Dysmorphic facial features, including widely spaced eyes and ptosis</div></li></ul><p>Additional features occurring frequently in NSML:</p><ul><li class="half_rhythm"><div>Variable degree of cognitive deficits</div></li><li class="half_rhythm"><div>Sensorineural hearing loss</div></li><li class="half_rhythm"><div>Cryptorchidism</div></li><li class="half_rhythm"><div>Skeletal anomalies</div></li><li class="half_rhythm"><div>Caf&#x000e9; au lait macules</div></li></ul></div><div id="leopard.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Noonan syndrome with multiple lentigines is established either clinically in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the following clinical findings or, if clinical findings are insufficient, by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of four genes (<i>PTPN11</i>, <i>RAF1</i>, <i>BRAF</i>, and <i>MAP2K1)</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1383/table/leopard.T.summary_of_molecular_genetic_t/?report=objectonly" target="object" rid-figpopup="figleopardTsummaryofmoleculargenetict" rid-ob="figobleopardTsummaryofmoleculargenetict">Table 1</a>).</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Multiple lentigines plus two of the other cardinal features; OR</div></li><li class="half_rhythm"><div>In the absence of lentigines, three of the other cardinal features plus a <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> with NSML [<a class="bk_pop" href="#leopard.REF.sarkozy.2008.13">Sarkozy et al 2008</a>]</div></li></ul><p><b>Molecular genetic testing</b> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>PTPN11</i>, <i>RAF1</i>, <i>BRAF</i>, <i>MAP2K1</i>, and other genes of interest (see <a href="#leopard.Differential_Diagnosis">Differential Diagnosis</a>(1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> of <i>PTPN11</i>, <i>RAF1,</i>
<i>BRAF</i>, and <i>MAP2K1</i> based on the order in which a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is most likely to be identified. Although gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> could be considered, the variant detection frequency is unknown and expected to be extremely low.</div></li></ul><div id="leopard.T.summary_of_molecular_genetic_t" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in Noonan Syndrome with Multiple Lentigines</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1383/table/leopard.T.summary_of_molecular_genetic_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leopard.T.summary_of_molecular_genetic_t_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of NSML Attributed to Mutation of This Gene</th><th id="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Variants Detected by Test Method</th></tr><tr><th headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3" id="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></th><th headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3" id="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTPN11</i></td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%</td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nearly 100%&#x000a0;<sup>4</sup></td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RAF1</i></td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nearly 100%&#x000a0;<sup>6</sup></td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BRAF</i></td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 individuals</td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 7</td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAP2K1</i></td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 individual</td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 8</td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>9</sup></td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%</td><td headers="hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_1_3 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_1 hd_h_leopard.T.summary_of_molecular_genetic_t_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="leopard.TF.1.1"><p class="no_margin">See <a href="/books/NBK1383/#leopard.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#leopard.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="leopard.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="leopard.TF.1.3"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used can include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>4. </dt><dd><div id="leopard.TF.1.4"><p class="no_margin">Most pathogenic variants causing NSML are identified in exons 7, 12, and 13 [<a class="bk_pop" href="#leopard.REF.digilio.2002.389">Digilio et al 2002</a>, <a class="bk_pop" href="#leopard.REF.legius.2002.571">Legius et al 2002</a>, <a class="bk_pop" href="#leopard.REF.sarkozy.2009.695">Sarkozy et al 2009</a>].</p></div></dd><dt>5. </dt><dd><div id="leopard.TF.1.5"><p class="no_margin">No <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> involving <i>PTPN11</i>or <i>RAF1</i> has been reported as causative of NSML. Based on the molecular mechanisms implicated in disease pathogenesis, exon or whole-gene deletions or duplications are not expected to cause NSML.</p></div></dd><dt>6. </dt><dd><div id="leopard.TF.1.6"><p class="no_margin">Sequence analysis of coding exons 6, 13, and 16 detects all reported pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants [<a class="bk_pop" href="#leopard.REF.pandit.2007.1007">Pandit et al 2007</a>].</p></div></dd><dt>7. </dt><dd><div id="leopard.TF.1.7"><p class="no_margin">Sequence analysis of all coding exons detected pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in two individuals with clinical features of NSML [<a class="bk_pop" href="#leopard.REF.sarkozy.2009.695">Sarkozy et al 2009</a>, <a class="bk_pop" href="#leopard.REF.koudova.2009.337">Koudova et al 2009</a>].</p></div></dd><dt>8. </dt><dd><div id="leopard.TF.1.8"><p class="no_margin">Sequence analysis of all coding exons detected pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in one individual with clinical features of NSML [<a class="bk_pop" href="#leopard.REF.nishi.2015.407">Nishi et al 2015</a>].</p></div></dd><dt>9. </dt><dd><div id="leopard.TF.1.9"><p class="no_margin">It is likely that one or more additional, as-yet undefined genes, possibly related to RAS signal transduction, are associated with the ~5% of individuals with NSML in whom no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in <i>PTPN11</i>, <i>RAF1,</i> or <i>BRAF</i>.</p></div></dd></dl></div></div></div></div></div><div id="leopard.Clinical_Characteristics"><h2 id="_leopard_Clinical_Characteristics_">Clinical Characteristics</h2><div id="leopard.Clinical_Description"><h3>Clinical Description</h3><p>Males are more likely than females to be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with Noonan syndrome with multiple lentigines (NSML) [<a class="bk_pop" href="#leopard.REF.voron.1976.447">Voron et al 1976</a>], either as a result of bias of ascertainment or preferential survival of affected male fetuses, as proposed for <a href="/books/n/gene/noonan/">Noonan syndrome</a> (NS) [<a class="bk_pop" href="#leopard.REF.tartaglia.2004a.492">Tartaglia et al 2004a</a>].</p><p><b>Dermatologic.</b> Multiple lentigines present as dispersed flat, black-brown macules, mostly on the face, neck, and upper part of the trunk with sparing of the mucosa. In general, lentigines do not appear until age four to five years but then increase into the thousands by puberty [<a class="bk_pop" href="#leopard.REF.coppin.1997.582">Coppin &#x00026; Temple 1997</a>]. Some individuals with NSML do not exhibit lentigines.</p><p>Caf&#x000e9; au lait macules are also observed in up to 70%-80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#leopard.REF.digilio.2006.740">Digilio et al 2006</a>], usually preceding the appearance of lentigines.</p><p>Skin hyperelasticity has also been described.</p><p><b>Cardiovascular.</b> Approximately 85% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have heart defects, which are similar to those observed in NS but with different frequencies [<a class="bk_pop" href="#leopard.REF.limongelli.2007.736">Limongelli et al 2007</a>].</p><p>Hypertrophic cardiomyopathy is detected in up to 70% of individuals with heart defects (compared to 25% in NS). It most commonly appears during infancy and can be progressive.</p><p>Pulmonary valve stenosis is noted in approximately 25% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Abnormalities of the aortic and mitral valves are also observed in a minority of persons with NSML.</p><p>ECG abnormalities, aside from those typically associated with hypertrophic cardiomyopathy, include conduction defects (23%).</p><p><b>Facial features.</b> Dysmorphic facial features are similar to those seen in Noonan syndrome, although usually milder [<a class="bk_pop" href="#leopard.REF.digilio.2006.740">Digilio et al 2006</a>]. Features include inverted triangular-shaped face, downslanted palpebral fissures, low-set posteriorly rotated ears with thickened helices, and widely spaced eyes. The neck can be short with excess nuchal skin and a low posterior hairline.</p><p><b>Hearing.</b> Sensorineural hearing deficits are present in approximately 20% of persons with NSML. Minimal information is available about the progression of deafness in those with milder degrees of hearing impairment.</p><p><b>Growth.</b> Birth weight is usually normal but may be above the 97th percentile. Postnatal growth retardation resulting in short stature is noted in fewer than 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, although most have a height that is less than the 25<sup>th</sup> percentile for age. Issues such as adult height and response to growth hormone therapy have not been studied in this disorder.</p><p><b>Psychomotor development.</b> Intellectual disability, typically mild, is observed in approximately 30% of persons with NSML. Specific information concerning the deficits typically found in these children is not available.</p><p><b>Genitourinary.</b> Cryptorchidism, unilateral or bilateral, is present in approximately one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males. Other abnormalities including hypospadias, urinary tract defects, and ovarian abnormalities are observed infrequently.</p></div><div id="leopard.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No clear-cut <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been observed among the <i>PTPN11</i> pathogenic variants causing NSML.</p><p>The two <i>RAF1</i> pathogenic variants observed in NSML (see <a class="figpopup" href="/books/NBK1383/table/leopard.T.raf1_pathogenic_variants_of_in/?report=objectonly" target="object" rid-figpopup="figleopardTraf1pathogenicvariantsofin" rid-ob="figobleopardTraf1pathogenicvariantsofin">Table 3</a>) reside in mutational hot spots strongly associated with hypertrophic cardiomyopathy [<a class="bk_pop" href="#leopard.REF.pandit.2007.1007">Pandit et al 2007</a>]. Of note, the <a class="figpopup" href="/books/NBK1383/table/leopard.T.raf1_pathogenic_variants_of_in/?report=objectonly" target="object" rid-figpopup="figleopardTraf1pathogenicvariantsofin" rid-ob="figobleopardTraf1pathogenicvariantsofin">p.Ser257Leu</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was associated with both NS and NSML [<a class="bk_pop" href="#leopard.REF.pandit.2007.1007">Pandit et al 2007</a>].</p><p>In addition to NSML in two persons, one third of persons with NS and a <i>RAF1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had other findings including multiple nevi, lentigines, and/or caf&#x000e9; au lait spots, suggesting a predisposition to hyperpigmented cutaneous lesions associated with these pathogenic variants.</p><p><a class="bk_pop" href="#leopard.REF.koudova.2009.337">Koudova et al [2009]</a> reported a person with NSML and normal intelligence who had a novel sequence change in <i>BRAF</i>, further illustrating that the phenotypic spectrum caused by <i>BRAF</i> pathogenic variants is broader than previously assumed and does not always include intellectual disability.</p></div><div id="leopard.Nomenclature"><h3>Nomenclature</h3><p>Noonan syndrome with multiple lentigines (NSML) was referred to as cardiomyopathic lentiginosis in the older medical literature.</p><p>Until recently, NSML was referred to as LEOPARD syndrome but this name is being phased out due to objections from some families with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children who found the term offensive.</p></div><div id="leopard.Penetrance"><h3>Penetrance</h3><p>Penetrance of NSML is difficult to determine because of ascertainment bias and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>, frequently with subtlety of phenotypic features. Affected adults may be diagnosed only after the birth of a more obviously <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infant.</p></div><div id="leopard.Prevalence"><h3>Prevalence</h3><p>The population prevalence of NSML is not known.</p></div></div><div id="leopard.Genetically_Related_Allelic_Diso"><h2 id="_leopard_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>The phenotypic overlap that occurs in individuals with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in genes causing Noonan syndrome with multiple lentigines, Noonan syndrome, and cardiofaciocutaneous syndrome emphasizes that these disorders (previously defined as distinct clinical entities) constitute a phenotypic continuum and yet highlights the usefulness of <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-based management.</p><div id="leopard.PTPN11"><h3><i>PTPN11</i></h3><p><a href="/books/n/gene/noonan/"><b>Noonan syndrome</b></a>
<b>(NS)</b> (short stature, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defect, broad or webbed neck, pectus deformities, developmental delay of variable degree, cryptorchidism, and characteristic facies) is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition with variable expression. It shows significant overlap with NSML, but <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are unlikely to have the profusion of pigmented lesions, lentigines, and caf&#x000e9; au lait patches or to be deaf. Pathogenic variants in exons 2-14 of <i>PTPN11</i> have been reported in approximately 50% of individuals with NS. These reports confirm that NSML and NS are allelic conditions but that particular <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> exist with certain pathogenic variants in <i>PTPN11</i> leading to the pigmentary changes and higher prevalence of HCM observed in NSML. NS is genetically heterogeneous, with pathogenic variants also identified in <i>KRAS</i>, <i>NRAS, SOS1</i>, <i>RAF1, BRAF</i>, and <i>RIT1</i> (&#x0003c;20% of cases).</p><p><b>Noonan-like/multiple giant-cell lesion syndrome (NL/MGCLS)</b> is characterized by some cardinal features of NS in association with giant cell lesions of bone and soft tissues (<a href="/books/n/gene/cherubism/">cherubism</a>). <i>PTPN11</i> pathogenic variants have been described in both <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> (i.e., a single occurrence in a family) cases.</p><p><a class="bk_pop" href="#leopard.REF.sarkozy.2004.1069">Sarkozy et al [2004]</a> reported a female whose early <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was typical of NS but who over time developed the hearing loss and lentigines characteristic of NSML. Thus, NL/MGCLS may be too limited and inaccurate a term; a variety of <i>PTPN11</i> pathogenic variants, some of them programming the phenotype of NS and others the phenotype of NSML, may also program the development of giant cell lesions.</p><p>Overall, NL/MGCLS-associated <i>PTPN11</i> pathogenic variants have been observed in individuals with NS, NSML, or cardiofaciocutaneous syndrome (CFCS), including families segregating the trait without any bony involvement. Thus, additional genetic factors may be necessary for the giant cell proliferation to occur. Consistent with this view, this trait is genetically heterogeneous with documented <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants affecting other NS/CFCS-related genes coding for transducers participating in the RAS-MAPK signalling pathway [<a class="bk_pop" href="#leopard.REF.beneteau.2009.1216">Beneteau et al 2009</a>, <a class="bk_pop" href="#leopard.REF.hanna.2009.568">Hanna et al 2009</a>, <a class="bk_pop" href="#leopard.REF.neumann.2009.420">Neumann et al 2009</a>].</p><p><b>Sporadic tumors (including leukemia and solid tumors)</b> occurring as single tumors in the absence of any other findings of NSML or Noonan syndrome frequently harbor somatic pathogenic variants in <i>PTPN11</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not heritable. For more details see <a href="#leopard.Molecular_Genetics">Molecular Genetics</a>, <b><i>PTPN11</i> cancer and benign tumors</b>.</p></div><div id="leopard.RAF1"><h3><i>RAF1</i></h3><p><a href="/books/n/gene/noonan/"><b>Noonan syndrome</b></a>
<b>(NS)</b> is also associated with <i>RAF1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants, with a prevalence ranging between 5% and 15% [<a class="bk_pop" href="#leopard.REF.pandit.2007.1007">Pandit et al 2007</a>, <a class="bk_pop" href="#leopard.REF.razzaque.2007.1013">Razzaque et al 2007</a>]. <i>RAF1</i> pathogenic variants underlying NS or NSML affect residues clustering in three regions of the protein:</p><ul><li class="half_rhythm"><div>The N-terminal consensus 14-3-3 recognition sequence (residues 256 to 261; see <a class="figpopup" href="/books/NBK1383/table/leopard.T.raf1_pathogenic_variants_of_in/?report=objectonly" target="object" rid-figpopup="figleopardTraf1pathogenicvariantsofin" rid-ob="figobleopardTraf1pathogenicvariantsofin">Table 3</a>) or adjacent residues in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3. Amino acid substitutions within this region account for approximately 70% of all <i>RAF1</i> pathogenic variants.</div></li><li class="half_rhythm"><div>Asp486 and Thr491 are residues within the activation segment region of the kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> encoded by <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 13; alterations in these amino acids constitute approximately 15% of <i>RAF1</i> pathogenic variants.</div></li><li class="half_rhythm"><div>Pathogenic variants in two adjacent residues in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 16 (Ser612 and Leu613; see <a class="figpopup" href="/books/NBK1383/table/leopard.T.raf1_pathogenic_variants_of_in/?report=objectonly" target="object" rid-figpopup="figleopardTraf1pathogenicvariantsofin" rid-ob="figobleopardTraf1pathogenicvariantsofin">Table 3</a>) account for 15% of <i>RAF1</i> pathogenic variants. These two residues are located at the C-terminus in proximity of Ser621, a residue that undergoes phosphorylation and is important for the regulation of the catalytic activation of RAF1.</div></li></ul><p>A large percentage (70%-90%) of persons with NS and a <i>RAF1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have hypertrophic cardiomyopathy (HCM), which is significantly higher than the 20% with HCM observed in the general NS population. Moreover, this <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation seems to be <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-specific, as HCM appears to be associated with pathogenic variants affecting the region encoding the N-terminal 14-3-3 consensus site or the C-terminus.</p><p><b>Sporadic solid tumors</b> occurring as single tumors in the absence of any other findings of NSML or Noonan syndrome frequently harbor somatic pathogenic variants in <i>RAF1</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not heritable. For more details see <a href="#leopard.Molecular_Genetics">Molecular Genetics</a>, <b><i>RAF1</i> cancer and benign tumors</b>.</p></div><div id="leopard.BRAF"><h3><i>BRAF</i></h3><p><a href="/books/n/gene/cfc/"><b>Cardiofaciocutaneous syndrome</b></a>
<b>(CFCS).</b> Pathogenic variants in four genes in the MAPK pathway (<i>BRAF</i>, <i>KRAS</i>, <i>MAP2K1</i>, and <i>MAP2K2</i>) have been demonstrated in individuals with CFCS [<a class="bk_pop" href="#leopard.REF.niihori.2006.294">Niihori et al 2006</a>, <a class="bk_pop" href="#leopard.REF.rodriguezviciana.2006.1287">Rodriguez-Viciana et al 2006</a>]. <i>BRAF</i> is mutated in 50%-75% of persons with CFCS [<a class="bk_pop" href="#leopard.REF.niihori.2006.294">Niihori et al 2006</a>, <a class="bk_pop" href="#leopard.REF.rodriguezviciana.2006.1287">Rodriguez-Viciana et al 2006</a>, <a class="bk_pop" href="#leopard.REF.sarkozy.2009.695">Sarkozy et al 2009</a>].</p><p>CFCS and NSML have similar cardiac findings; however, in CFCS, intellectual disability is usually more severe, with a higher likelihood of structural central nervous system anomalies; more florid skin pathology; and more severe and long-lasting gastrointestinal problems. In CFCS, facial appearance tends to be coarser; dolichocephaly and absent eyebrows are more common; and blue eyes are less common.</p><p>Analysis of the clinical features of persons with CFCS who have a <i>BRAF</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> indicated a wide phenotypic variability, although all displayed typical <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facies, cardiac defects, and skin and skeletal anomalies. Moderate-to-severe intellectual disability, observed in most, is commonly associated with seizures or hypotonia. Pigmentary changes including caf&#x000e9; au lait spots, nevi, and lentigines are common [<a class="bk_pop" href="#leopard.REF.niihori.2006.294">Niihori et al 2006</a>, <a class="bk_pop" href="#leopard.REF.rodriguezviciana.2006.1287">Rodriguez-Viciana et al 2006</a>, <a class="bk_pop" href="#leopard.REF.sarkozy.2009.695">Sarkozy et al 2009</a>].</p><p><a href="/books/n/gene/noonan/"><b>Noonan syndrome</b></a>
<b>(NS).</b>
<i>BRAF</i> is rarely mutated in NS (~2% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#leopard.REF.sarkozy.2009.695">Sarkozy et al 2009</a>]. The <i>BRAF</i> pathogenic variants observed in NS largely do not overlap with those occurring in CFCS, suggesting a <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation.</p><p><b>Sporadic solid tumors</b> occurring as single tumors in the absence of any other findings of NSML frequently harbor somatic pathogenic variants in <i>BRAF</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not heritable. For more details see <a href="#leopard.Molecular_Genetics">Molecular Genetics</a>, <b><i>BRAF</i> cancer and benign tumors</b>.</p></div><div id="leopard.MAP2K1"><h3><i>MAP2K1</i></h3><p><a href="/books/n/gene/cfc/"><b>Cardiofaciocutaneous syndrome</b></a>
<b>(CFCS).</b> Pathogenic variants in <i>MAP2K1</i> have been reported in individuals with CFCS [<a class="bk_pop" href="#leopard.REF.rodriguezviciana.2006.1287">Rodriguez-Viciana et al 2006</a>, <a class="bk_pop" href="#leopard.REF.nava.2007.763">Nava et al 2007</a>, <a class="bk_pop" href="#leopard.REF.dentici.2009.733">Dentici et al 2009</a>]. <i>MAP2K1</i> is mutated in approximately 10%-15% of individuals with CFCS [<a class="bk_pop" href="#leopard.REF.dentici.2009.733">Dentici et al 2009</a>].</p><p>The clinical features of those with CFCS who have a <i>MAP2K1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> fall into the "classic" CFCS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, particularly regarding the presence of <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features, short stature, ectodermal findings, and cognitive deficits [<a class="bk_pop" href="#leopard.REF.rodriguezviciana.2006.1287">Rodriguez-Viciana et al 2006</a>, <a class="bk_pop" href="#leopard.REF.nava.2007.763">Nava et al 2007</a>, <a class="bk_pop" href="#leopard.REF.dentici.2009.733">Dentici et al 2009</a>].</p><p><a href="/books/n/gene/noonan/"><b>Noonan syndrome</b></a>
<b>(NS).</b>
<i>MAP2K1</i> is rarely mutated in NS [<a class="bk_pop" href="#leopard.REF.nava.2007.763">Nava et al 2007</a>, <a class="bk_pop" href="#leopard.REF.chen.2014.11473">Chen et al 2014</a>]. Three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (p.Asp67Asn) not previously reported in CFCS, suggesting a <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation.</p></div></div><div id="leopard.Differential_Diagnosis"><h2 id="_leopard_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Turner syndrome,</b> found only in females, is distinguished from Noonan syndrome with multiple lentigines (NSML) by demonstration of an X-<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormality on <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> studies. The characteristic facial features are also distinct, and in Turner syndrome renal anomalies are more common, developmental delay is much less frequently found, and left-sided heart defects are the rule.</p><p>The <b>Watson syndrome</b> (OMIM <a href="http://omim.org/entry/193520" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">193520</a>) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> also overlaps with that of <a href="/books/n/gene/nf1/">neurofibromatosis type 1</a> and the two are now known to be allelic. Variably present in both Watson syndrome and NSML are short stature, pulmonary valve stenosis, variable intellectual development, and skin pigment changes including caf&#x000e9; au lait macules. Lentigines are not described in Watson syndrome. Heterozygous pathogenic variants in <i>NF1</i> are causative.</p><p><a href="/books/n/gene/costello/"><b>Costello syndrome</b></a>
<b>(CS)</b> shares features with NSML, <a href="/books/n/gene/noonan/">NS</a>, and <a href="/books/n/gene/cfc/">CFCS</a>. Two series of individuals with CS have been studied molecularly and no <i>PTPN11</i> has been identified [<a class="bk_pop" href="#leopard.REF.tartaglia.2003a.423">Tartaglia et al 2003a</a>, <a class="bk_pop" href="#leopard.REF.tr_ger.2003.82">Tr&#x000f6;ger et al 2003</a>]. Germline pathogenic variants predominantly in the first and third coding exons of the <i>HRAS</i> proto-oncogene have been shown to cause CS [<a class="bk_pop" href="#leopard.REF.aoki.2005.1038">Aoki et al 2005</a>].</p><p><b>Other.</b> NSML should be distinguished from other syndromes with developmental delay, short stature, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, and distinctive facies, especially <a href="/books/n/gene/williams/">Williams syndrome</a>.</p></div><div id="leopard.Management"><h2 id="_leopard_Management_">Management</h2><div id="leopard.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Noonan syndrome with multiple lentigines (NSML), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Complete physical and neurologic examination</div></li><li class="half_rhythm"><div>Plotting of growth parameters on <a href="/books/n/gene/noonan/">Noonan syndrome</a> growth charts by <a class="bk_pop" href="#leopard.REF.witt.1986.150">Witt et al [1986]</a> (Specific growth charts for NSML are not available.)</div></li><li class="half_rhythm"><div>Cardiac evaluation with echocardiography and electrocardiography</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Hearing evaluation including complete assessment of auditory acuity using age-appropriate tests (e.g., ABR testing, auditory steady-state response [ASSR] testing, pure tone audiometry)</div></li><li class="half_rhythm"><div>Renal ultrasound examination; urinalysis if urinary tract abnormalities are identified</div></li><li class="half_rhythm"><div>Clinical and radiographic assessment of spine and rib cage</div></li><li class="half_rhythm"><div>Brain and cervical spine MRI if neurologic symptoms are present</div></li><li class="half_rhythm"><div>Multidisciplinary developmental evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="leopard.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment of cardiovascular anomalies and cryptorchidism is usually the same as in the general population.</p><p>Treatment of hearing loss may include the following:</p><ul><li class="half_rhythm"><div>Fitting with appropriate hearing aids</div></li><li class="half_rhythm"><div>Enrollment in an appropriate educational program for the hearing impaired</div></li><li class="half_rhythm"><div>Consideration for cochlear implantation, a promising habilitation option for persons with profound deafness</div></li><li class="half_rhythm"><div>Recognition that, as distinct from many clinical conditions, the management and treatment of severe-to-profound <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> deafness involves primarily the social welfare and educational systems rather than the medical care system [<a class="bk_pop" href="#leopard.REF.smith.2005.879">Smith et al 2005</a>]</div></li></ul><p>Any developmental disability should be addressed by early intervention programs and individualized education strategies.</p><p>Treatment of cryptorchidism in males is usually the same as in the general population.</p></div><div id="leopard.Prevention_of_Secondary_Complica"><h3>Prevention of Secondary Complications</h3><p>For individuals with hypertrophic cardiomyopathy, certain physical activities may be curtailed in order to reduce the risk of sudden cardiac death.</p><p>For individuals diagnosed in infancy, early intervention may limit the extent of intellectual and developmental disabilities.</p></div><div id="leopard.Surveillance"><h3>Surveillance</h3><p>If anomalies are found in any system, periodic follow up should be planned and lifelong monitoring may be necessary, especially of cardiovascular abnormalities.</p><p>For hearing loss, twice-yearly examination by a physician familiar with hereditary hearing impairment and repeat audiometry to confirm the stability of the hearing loss is recommended.</p><p>Surveillance for intellectual and developmental disabilities as per routine pediatric care is of particular importance due to the higher prevalence of these issues in individuals with NSML.</p><p>Surveillance for growth delay as per routine pediatric care is important due to the higher prevalence of poor linear growth in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children.</p></div><div id="leopard.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>For individuals with hypertrophic cardiomyopathy, treatment with growth hormone must be undertaken with great caution, if at all, to avoid exacerbating a cardiac condition.</p></div><div id="leopard.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p><ul><li class="half_rhythm"><div>If the <i>PTPN11</i>, <i>RAF1,</i>
<i>BRAF</i>, or <i>MAP2K1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk relatives.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known, a thorough physical examination with particular attention to the features of NSML may clarify the disease status of at-risk relatives.</div></li></ul><p>See <a href="#leopard.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="leopard.Pregnancy_Management"><h3>Pregnancy Management</h3><p>For <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women, cardiac status should be monitored during pregnancy. Those with hypertrophic cardiomyopathy or valve dysfunction may be at risk for the development or exacerbation of heart failure during pregnancy, especially during the second and third trimesters.</p></div><div id="leopard.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Clinical Trials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="leopard.Genetic_Counseling"><h2 id="_leopard_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="leopard.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Noonan syndrome with multiple lentigines (NSML) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="leopard.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with NSML have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with NSML may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>PTPN11</i>, <i>RAF1,</i>
<i>BRAF,</i> or <i>MAP2K1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include a thorough physical examination with particular attention to the features of NSML.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with NSML may appear to be negative because of failure to recognize the disorder in family members. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></div></li></ul><p>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the pathogenic variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>If the <i>PTPN11</i>, <i>RAF1,</i>
<i>BRAF,</i> or <i>MAP2K1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with NSML has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="leopard.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#leopard.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with NSML has the pathogenic variant, the <i>PTPN11</i>, <i>RAF1,</i>
<i>BRAF,</i> or <i>MAP2K1</i> pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="leopard.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>PTPN11</i>, <i>RAF1,</i>
<i>BRAF,</i> or <i>MAP2K1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="leopard.Resources"><h2 id="_leopard_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001473.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Multiple lentigines syndrome</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=LEOPARD%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LEOPARD syndrome</a></div></li><li class="half_rhythm"><div><b>RASopathiesNet</b></div><div>244 Taos Road</div><div>Atlandena CA 91001</div><div><b>Phone:</b> 626-676-7694</div><div><b>Email:</b> lisa@rasopathies.org</div><div><a href="http://rasopathiesnet.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rasopathiesnet.org</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>Children's Heart Foundation</b></div><div>PO Box 244</div><div>Lincolnshire IL 60069-0244</div><div><b>Phone:</b> 888-248-8140 (toll-free); 847-634-6474</div><div><b>Fax:</b> 847-634-4988</div><div><b>Email:</b> info@childrensheartfoundation.org</div><div><a href="http://www.childrensheartfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childrensheartfoundation.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li></ul></div><div id="leopard.Molecular_Genetics"><h2 id="_leopard_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="leopard.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Noonan Syndrome with Multiple Lentigines: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1383/table/leopard.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leopard.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_leopard.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_leopard.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_leopard.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_leopard.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_leopard.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_leopard.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_leopard.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/673" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>BRAF</i></a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=673" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q34</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P15056" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Serine/threonine-protein kinase B-raf</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/BRAF" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BRAF database</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=BRAF" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BRAF</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=BRAF[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BRAF</a></td></tr><tr><td headers="hd_b_leopard.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5604" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MAP2K1</i></a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5604" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q22<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q02750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dual specificity mitogen-activated protein kinase kinase 1</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/MAP2K1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MAP2K1 @ LOVD</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MAP2K1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MAP2K1</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MAP2K1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MAP2K1</a></td></tr><tr><td headers="hd_b_leopard.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5781" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PTPN11</i></a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5781" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q24<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q06124" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tyrosine-protein phosphatase non-receptor type 11</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PTPN11" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PTPN11 database</a><br /><a href="http://structure.bmc.lu.se/idbase/PTPN11base/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PTPN11base: Database for pathogenic mutations in the SHP-2 SH2 domain</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PTPN11" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PTPN11</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PTPN11[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PTPN11</a></td></tr><tr><td headers="hd_b_leopard.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5894" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RAF1</i></a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5894" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p25<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P04049" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RAF proto-oncogene serine/threonine-protein kinase</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_leopard.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RAF1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RAF1</a></td><td headers="hd_b_leopard.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RAF1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RAF1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="leopard.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="leopard.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Noonan Syndrome with Multiple Lentigines (<a href="/omim/151100,164757,164760,176872,176876,611554,613707" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1383/table/leopard.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leopard.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/151100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">151100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEOPARD SYNDROME 1; LPRD1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/164757" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">164757</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1; BRAF</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/164760" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">164760</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">V-RAF-1 MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; RAF1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176872" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176872</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; MAP2K1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176876" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176876</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11; PTPN11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611554" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611554</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEOPARD SYNDROME 2; LPRD2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613707" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613707</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEOPARD SYNDROME 3; LPRD3</td></tr></tbody></table></div></div><p><b><i>PTPN11</i></b></p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has 15 exons. For a detailed summary of gene and protein information, see <a href="/books/NBK1383/#leopard.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK1383/table/leopard.T.selected_ptpn11_pathogenic_var/?report=objectonly" target="object" rid-figpopup="figleopardTselectedptpn11pathogenicvar" rid-ob="figobleopardTselectedptpn11pathogenicvar">Table 2</a>. Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <i>PTPN11</i> were identified in 90% of individuals with Noonan syndrome with multiple lentigines (NSML) examined. Pathogenic variants alter residues at or close to the N-SH2/PTP interacting surfaces, which are involved in switching between active and inactive conformations of the protein, and participating in catalysis. Biochemical characterization of a panel of mutants documented that NSML-associated pathogenic variants impair catalytic activity [<a class="bk_pop" href="#leopard.REF.hanna.2006.2477">Hanna et al 2006</a>, <a class="bk_pop" href="#leopard.REF.kontaridis.2006.6785">Kontaridis et al 2006</a>, <a class="bk_pop" href="#leopard.REF.tartaglia.2006.279">Tartaglia et al 2006</a>].</p><div id="leopard.T.selected_ptpn11_pathogenic_var" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>PTPN11</i> Pathogenic Variants of Interest Including Those Causing Noonan Syndrome with Multiple Lentigines</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1383/table/leopard.T.selected_ptpn11_pathogenic_var/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leopard.T.selected_ptpn11_pathogenic_var_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.836A&#x0003e;G</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr279Cys</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_3" rowspan="9" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/33356176" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002834<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/33356177" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002825<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.836A&#x0003e;C</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr279Ser</td></tr><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1381G&#x0003e;A</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala461Thr</td></tr><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1391G&#x0003e;C</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly464Ala</td></tr><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1403C&#x0003e;T</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr468Met</td></tr><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1492C&#x0003e;T</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg498Leu</td></tr><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1493G&#x0003e;T</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg498Trp</td></tr><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1517A&#x0003e;C</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln506Pro</td></tr><tr><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1528C&#x0003e;G</td><td headers="hd_h_leopard.T.selected_ptpn11_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln510Glu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>PTPN11</i> encodes tyrosine-protein phosphatase non-receptor type 11 (also known as protein tyrosine phosphatase non-receptor type 11, or SHP-2), a widely expressed intracellular protein. The protein is a key molecule in the cellular response to growth factors, hormones, cytokines, and cell adhesion molecules [<a class="bk_pop" href="#leopard.REF.neel.2003.284">Neel et al 2003</a>]. It is required in several intracellular signal transduction pathways that control diverse developmental processes (including cardiac semilunar valvulogenesis and blood cell progenitor commitment and differentiation) and has a role in modulating cellular proliferation, differentiation, migration, and apoptosis. The protein has two tandemly arranged SRC-homology 2 (SH2) domains at the N-terminus (N-SH2 and C-SH2), a single catalytic protein tyrosine phosphatase (PTP) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, and a C-terminal tail with two tyrosyl phosphorylation sites and a proline-rich stretch. The N-SH2-PTP interaction maintains the protein in an inactive state.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Aberrant function of SHP-2 causes dysregulation of growth factor and cytokine-mediated RAS/ERK/MAPK and PI3K/AKT signal flow, perturbing cell proliferation [<a class="bk_pop" href="#leopard.REF.fragale.2004.267">Fragale et al 2004</a>, <a class="bk_pop" href="#leopard.REF.chan.2005.3737">Chan et al 2005</a>, <a class="bk_pop" href="#leopard.REF.keilhack.2005.30984">Keilhack et al 2005</a>, <a class="bk_pop" href="#leopard.REF.hanna.2006.2477">Hanna et al 2006</a>, <a class="bk_pop" href="#leopard.REF.kontaridis.2006.6785">Kontaridis et al 2006</a>].</p><p><b>Leukemia and solid tumors.</b> Juvenile myelomonocytic leukemia (JMML) accounts for one third of childhood cases of myelodysplastic syndrome (MDS) and about 2% of leukemia. Pathogenic variants in <i>NRAS, KRAS</i>, and <i>NF1</i> have been shown to deregulate the RAS/MAPK pathway leading to JMML in about 40% of cases. Somatic pathogenic variants in exons 3 and 13 of <i>PTPN11</i> have been demonstrated in 34% of a cohort of individuals with JMML [<a class="bk_pop" href="#leopard.REF.tartaglia.2003b.148">Tartaglia et al 2003b</a>]. Pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 were also found in 19% of children with MDS with an excess of blast cells, which often evolves into acute myeloid leukemia (AML) and is associated with poor prognosis. Nonsyndromic AML, especially the monocyte subtype FAB-M5, has been shown to be caused by <i>PTPN11</i> pathogenic variants. All of these pathogenic variants result in a gain of function of the protein tyrosine phosphatase non-receptor type 11 (SHP-2), likely leading to an early initiating lesion in JMML oncogenesis with increased cell proliferation attributable, in part, to prolonged activation of the RAS/MAPK pathway.</p><p>The spectrum of leukemogenesis associated with <i>PTPN11</i> pathogenic variants has been extended to include childhood acute lymphoblastic leukemia (ALL). Pathogenic variants were observed in 8% of B-cell precursor ALL cases, but not among children with T-lineage ALL [<a class="bk_pop" href="#leopard.REF.tartaglia.2004b.307">Tartaglia et al 2004b</a>]. Additionally, SHP-2-activating <i>PTPN11</i> pathogenic variants have been found rarely in solid tumors including breast, lung, and gastric neoplasms and neuroblastoma [<a class="bk_pop" href="#leopard.REF.bentiresalj.2004.8816">Bentires-Alj et al 2004</a>].</p><p><b><i>RAF1</i></b></p><p><b>Gene structure.</b>
<i>RAF1</i> comprises 17 exons. It has three conserved regions (CR): CR1, encoded by exons 2-5, contains a RAS-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (RBD) and a cysteine-rich domain (CRD); CR2 is encoded by <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7; CR3, encoded by exons 10-17, contains the kinase domain and its regulatory element, the activation segment. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1383/#leopard.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK1383/table/leopard.T.raf1_pathogenic_variants_of_in/?report=objectonly" target="object" rid-figpopup="figleopardTraf1pathogenicvariantsofin" rid-ob="figobleopardTraf1pathogenicvariantsofin">Table 3</a>. The consensus 14-3-3 recognition site includes residues Arg256, Ser257, Ser259, and Pro261, and is encoded by <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7 (coding exon 6). One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in NSML (p.Ser257Leu) altered this CR2 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, interfered with 14-3-3 binding, and caused greater kinase activity than <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> protein, both basally and after stimulation [<a class="bk_pop" href="#leopard.REF.pandit.2007.1007">Pandit et al 2007</a>].</p><p>The other NSML-associated <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, p.Leu613Val, altered the C-terminal portion of RAF1 (coding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 16). This pathogenic variant also caused greater kinase activity than <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> protein, both basally and after EGF stimulation.</p><div id="leopard.T.raf1_pathogenic_variants_of_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>RAF1</i> Pathogenic Variants of Interest Including Those Causing Noonan Syndrome with Multiple Lentigines</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1383/table/leopard.T.raf1_pathogenic_variants_of_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leopard.T.raf1_pathogenic_variants_of_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leopard.T.raf1_pathogenic_variants_of_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_leopard.T.raf1_pathogenic_variants_of_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_leopard.T.raf1_pathogenic_variants_of_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequence</th></tr></thead><tbody><tr><td headers="hd_h_leopard.T.raf1_pathogenic_variants_of_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.770C&#x0003e;T</td><td headers="hd_h_leopard.T.raf1_pathogenic_variants_of_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser257Leu</td><td headers="hd_h_leopard.T.raf1_pathogenic_variants_of_in_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/52486392" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002880<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/4506401" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002871<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_leopard.T.raf1_pathogenic_variants_of_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1837C&#x0003e;G</td><td headers="hd_h_leopard.T.raf1_pathogenic_variants_of_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu613Val</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>RAF1</i> is ubiquitously expressed and encodes a protein of 648 amino acids with three domains. CR1 contains a Ras-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>; CR2 is a site of regulatory phosphorylation and association with the 14-3-3 protein. CR1 and CR2 both have negative regulatory function, removal of which results in oncogenic activity. The kinase domain, CR3, also associates with 14-3-3.</p><p>The protein is highly regulated with numerous serine and threonine residues that can be phosphorylated, resulting in activation or inactivation. The serine at residue 259, which is in CR2, is particularly important. In the inactive state, the N-terminus of RAF1 interacts with and inactivates the kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> at the C-terminus. This conformation is stabilized by 14-3-3 protein dimers that bind to phosphorylated Ser259 and Ser261. Dephosphorylation of Ser259 facilitates binding of RAF1 to RAS-GTP and propagation of the signal through the RAS-MAPK cascade via RAF1 MEK kinase activity.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> NSML-associated <i>RAF1</i> pathogenic variants increase and prolong RAS downstream signaling through enhanced kinase activity, leading to increased activation of MAP kinase kinases (<i>MAP2K1</i> and <i>MAP2K2</i>).</p><p><b><i>RAF1</i> cancer and benign tumors.</b> Almost none of the <i>RAF1</i> residues mutated in NS (and NSML) are altered in cancer.</p><p><b><i>BRAF</i></b></p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has 18 exons. For a detailed summary of gene and protein information, see <a href="/books/NBK1383/#leopard.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Two <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> changes affecting <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6 have been reported in two persons with a diagnosis of NSML (see <a class="figpopup" href="/books/NBK1383/table/leopard.T.braf_pathogenic_variants_causi/?report=objectonly" target="object" rid-figpopup="figleopardTbrafpathogenicvariantscausi" rid-ob="figobleopardTbrafpathogenicvariantscausi">Table 4</a>) [<a class="bk_pop" href="#leopard.REF.koudova.2009.337">Koudova et al 2009</a>, <a class="bk_pop" href="#leopard.REF.sarkozy.2009.695">Sarkozy et al 2009</a>].</p><div id="leopard.T.braf_pathogenic_variants_causi" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>BRAF</i> Pathogenic Variants Causing Noonan Syndrome with Multiple Lentigines</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1383/table/leopard.T.braf_pathogenic_variants_causi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leopard.T.braf_pathogenic_variants_causi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leopard.T.braf_pathogenic_variants_causi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_leopard.T.braf_pathogenic_variants_causi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_leopard.T.braf_pathogenic_variants_causi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequence</th></tr></thead><tbody><tr><td headers="hd_h_leopard.T.braf_pathogenic_variants_causi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.721A&#x0003e;C</td><td headers="hd_h_leopard.T.braf_pathogenic_variants_causi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr241Pro</td><td headers="hd_h_leopard.T.braf_pathogenic_variants_causi_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/187608632" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004333<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/33188459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004324<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_leopard.T.braf_pathogenic_variants_causi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.735A&#x0003e;T</td><td headers="hd_h_leopard.T.braf_pathogenic_variants_causi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu245Phe</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Exons 3-6, encode a RAS-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (RBD) and a cysteine-rich domain (CRD), while the kinase domain is encoded by exons 11-17. <i>BRAF</i> is ubiquitously expressed and encodes a protein of 766 amino acids. It is activated following GTP-bound RAS binding, and phosphorylates and activates the dual specificity mitogen-activated protein kinase kinases (<i>MAP2K1</i> and <i>MAP2K2</i>).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The NSML-associated p.Thr241Pro <i>BRAF</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> enhances RAS signaling through increased activation of MEK and ERK kinases [<a class="bk_pop" href="#leopard.REF.sarkozy.2009.695">Sarkozy et al 2009</a>]. NIH-3T3 cell colony focus formation assay data indicate that associated (p.Thr241Pro) BRAF mutants do not confer enhanced transformation to cells [<a class="bk_pop" href="#leopard.REF.sarkozy.2009.695">Sarkozy et al 2009</a>].</p><p><b><i>BRAF</i> cancer and benign tumors.</b>
<i>BRAF</i> variants mutated in solid tumors (p.Asp594Gly and p.Thr599Ile) alter the functional activation segment [<a class="bk_pop" href="#leopard.REF.pandit.2007.1007">Pandit et al 2007</a>].</p><p>Note: No occurrence of the common <i>BRAF</i> oncogenic somatic p.Val600Glu amino acid substitution has been documented to occur as a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> event associated with CFCS, NS, or NSML.</p><p><b><i>MAP2K1</i></b></p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has 11 exons. For a detailed summary of gene and protein information, see <a href="/books/NBK1383/#leopard.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> One <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant affecting <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2, c.305A&#x0003e;G (p.Glu102Gly), has been reported in one subject with a diagnosis of NSML (see <a class="figpopup" href="/books/NBK1383/table/leopard.T.map2k1_pathogenic_variants_of/?report=objectonly" target="object" rid-figpopup="figleopardTmap2k1pathogenicvariantsof" rid-ob="figobleopardTmap2k1pathogenicvariantsof">Table 5</a>) [<a class="bk_pop" href="#leopard.REF.nishi.2015.407">Nishi et al 2015</a>].</p><div id="leopard.T.map2k1_pathogenic_variants_of" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>MAP2K1</i> Pathogenic Variants of Interest Including Those Causing Noonan Syndrome with Multiple Lentigines</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1383/table/leopard.T.map2k1_pathogenic_variants_of/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leopard.T.map2k1_pathogenic_variants_of_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leopard.T.map2k1_pathogenic_variants_of_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_leopard.T.map2k1_pathogenic_variants_of_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_leopard.T.map2k1_pathogenic_variants_of_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequence</th></tr></thead><tbody><tr><td headers="hd_h_leopard.T.map2k1_pathogenic_variants_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.199G&#x0003e;A</td><td headers="hd_h_leopard.T.map2k1_pathogenic_variants_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp67Asn</td><td headers="hd_h_leopard.T.map2k1_pathogenic_variants_of_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002755.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002755<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_002746.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002746<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_leopard.T.map2k1_pathogenic_variants_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.305A&#x0003e;G</td><td headers="hd_h_leopard.T.map2k1_pathogenic_variants_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu102Gly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Exon 2 encodes the N-terminal portion of the catalytic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. The gene is widely expressed and encodes a protein of 393 amino acid residues. MAP2K1 is a dual specificity protein kinase. It is activated following phosphorylation by kinases of the RAF family, and phosphorylates and activates the mitogen-activated protein kinases (MAP1K1 and MAP1K2).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The NSML-associated p.Glu102Gly <i>MAP2K1</i> variant has not been characterized biochemically or functionally, but is predicted to enhance signaling through the MAPK cascade.</p></div><div id="leopard.References"><h2 id="_leopard_References_">References</h2><div id="leopard.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.aoki.2005.1038">Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, Filocamo M, Kato K, Suzuki Y, Kure S, Matsubara Y. Germline mutations in HRAS proto-oncogene cause Costello syndrome. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:1038–40.</span> [<a href="/pubmed/16170316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16170316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.beneteau.2009.1216">Beneteau C, Cav&#x000e9; H, Moncla A, Dorison N, Munnich A, Verloes A, Leheup B. SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:1216–21.</span> [<a href="/pmc/articles/PMC2986637/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986637</span></a>] [<a href="/pubmed/19352411" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19352411</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.bentiresalj.2004.8816">Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. <span><span class="ref-journal">Cancer Res. </span>2004;<span class="ref-vol">64</span>:8816–20.</span> [<a href="/pubmed/15604238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15604238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.chan.2005.3737">Chan RJ, Leedy MB, Munugalavadla V, Voorhorst CS, Li Y, Yu M, Kapur R. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">105</span>:3737–42.</span> [<a href="/pmc/articles/PMC1895012/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1895012</span></a>] [<a href="/pubmed/15644411" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15644411</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.chen.2014.11473">Chen PC, Yin J, Yu HW, Yuan T, Fernandez M, Yung CK, Trinh QM, Peltekova VD, Reid JG, Tworog-Dube E, Morgan MB, Muzny DM, Stein L, McPherson JD, Roberts AE, Gibbs RA, Neel BG, Kucherlapati R. Next-generation sequencing identifies rare variants associated with Noonan syndrome. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2014;<span class="ref-vol">111</span>:11473–8.</span> [<a href="/pmc/articles/PMC4128129/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4128129</span></a>] [<a href="/pubmed/25049390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25049390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.coppin.1997.582">Coppin BD, Temple IK. Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis). <span><span class="ref-journal">J Med Genet. </span>1997;<span class="ref-vol">34</span>:582–6.</span> [<a href="/pmc/articles/PMC1051000/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051000</span></a>] [<a href="/pubmed/9222968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9222968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.dentici.2009.733">Dentici ML, Sarkozy A, Pantaleoni F, Carta C, Lepri F, Ferese R, Cordeddu V, Martinelli S, Briuglia S, Digilio MC, Zampino G, Tartaglia M, Dallapiccola B. Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:733–40.</span> [<a href="/pmc/articles/PMC2947095/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2947095</span></a>] [<a href="/pubmed/19156172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19156172</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.digilio.2002.389">Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:389–94.</span> [<a href="/pmc/articles/PMC379170/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC379170</span></a>] [<a href="/pubmed/12058348" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12058348</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.digilio.2006.740">Digilio MC, Sarkozy A, de Zorzi A, Pacileo G, Limongelli G, Mingarelli R, Calabro R, Marino B, Dallapiccola B. LEOPARD syndrome: clinical diagnosis in the first year of life. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:740–6.</span> [<a href="/pubmed/16523510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16523510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.fragale.2004.267">Fragale A, Tartaglia M, Wu J, Gelb BD. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">23</span>:267–77.</span> [<a href="/pubmed/14974085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14974085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.hanna.2006.2477">Hanna N, Montagner A, Lee WH, Miteva M, Vidal M, Vidaud M, Parfait B, Raynal P. Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1. <span><span class="ref-journal">FEBS Lett. </span>2006;<span class="ref-vol">580</span>:2477–82.</span> [<a href="/pubmed/16638574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16638574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.hanna.2009.568">Hanna N, Parfait B, Talaat IM, Vidaud M, Elsedfy HH. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">75</span>:568–71.</span> [<a href="/pubmed/19438935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19438935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.keilhack.2005.30984">Keilhack H, David FS, McGregor M, Cantley LC, Neel BG. Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:30984–93.</span> [<a href="/pubmed/15987685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15987685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.kontaridis.2006.6785">Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:6785–92.</span> [<a href="/pubmed/16377799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16377799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.koudova.2009.337">Koudova M, Seemanova E, Zenker M. Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence. <span><span class="ref-journal">Eur J Med Genet. </span>2009;<span class="ref-vol">52</span>:337–40.</span> [<a href="/pubmed/19416762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19416762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.legius.2002.571">Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns JP. PTPN11 mutations in LEOPARD syndrome. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:571–4.</span> [<a href="/pmc/articles/PMC1735195/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735195</span></a>] [<a href="/pubmed/12161596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12161596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.limongelli.2007.736">Limongelli G, Pacileo G, Marino B, Digilio MC, Sarkozy A, Elliott P, Versacci P, Calabro P, De Zorzi A, Di Salvo G, Syrris P, Patton M, McKenna WJ, Dallapiccola B, Calabro R. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. <span><span class="ref-journal">Am J Cardiol. </span>2007;<span class="ref-vol">100</span>:736–41.</span> [<a href="/pubmed/17697839" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17697839</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.nava.2007.763">Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Niihori T, Aoki Y, Matsubara Y, Arveiler B, Lacombe D, Pasmant E, Parfait B, Baumann C, H&#x000e9;ron D, Sigaudy S, Toutain A, Rio M, Goldenberg A, Leheup B, Verloes A, Cav&#x000e9; H. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:763–71.</span> [<a href="/pmc/articles/PMC2652823/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2652823</span></a>] [<a href="/pubmed/17704260" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17704260</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.neel.2003.284">Neel BG, Gu H, Pao L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. <span><span class="ref-journal">Trends Biochem Sci. </span>2003;<span class="ref-vol">28</span>:284–93.</span> [<a href="/pubmed/12826400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12826400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.neumann.2009.420">Neumann TE, Allanson J, Kavamura I, Kerr B, Neri G, Noonan J, Cordeddu V, Gibson K, Tzschach A, Kr&#x000fc;ger G, Hoeltzenbein M, Goecke TO, Kehl HG, Albrecht B, Luczak K, Sasiadek MM, Musante L, Laurie R, Peters H, Tartaglia M, Zenker M, Kalscheuer V. Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:420–5.</span> [<a href="/pmc/articles/PMC2986220/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986220</span></a>] [<a href="/pubmed/18854871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18854871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.niihori.2006.294">Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, Okamoto N, Hennekam RC, Gillessen-Kaesbach G, Wieczorek D, Kavamura MI, Kurosawa K, Ohashi H, Wilson L, Heron D, Bonneau D, Corona G, Kaname T, Naritomi K, Baumann C, Matsumoto N, Kato K, Kure S, Matsubara Y. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:294–6.</span> [<a href="/pubmed/16474404" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16474404</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.nishi.2015.407">Nishi E, Mizuno S, Nanjo Y, Niihori T, Fukushima Y, Matsubara Y, Aoki Y, Kosho T. A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:407–11.</span> [<a href="/pubmed/25423878" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25423878</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.pandit.2007.1007">Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, Pogna EA, Schackwitz W, Ustaszewska A, Landstrom A, Bos JM, Ommen SR, Esposito G, Lepri F, Faul C, Mundel P, Lopez Siguero JP, Tenconi R, Selicorni A, Rossi C, Mazzanti L, Torrente I, Marino B, Digilio MC, Zampino G, Ackerman MJ, Dallapiccola B, Tartaglia M, Gelb BD. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1007–12.</span> [<a href="/pubmed/17603483" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17603483</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.razzaque.2007.1013">Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, Kamisago M, Momma K, Katayama H, Nakagawa M, Fujiwara Y, Matsushima M, Mizuno K, Tokuyama M, Hirota H, Muneuchi J, Higashinakagawa T, Matsuoka R. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1013–7.</span> [<a href="/pubmed/17603482" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17603482</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.rodriguezviciana.2006.1287">Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. <span><span class="ref-journal">Science. </span>2006;<span class="ref-vol">311</span>:1287–90.</span> [<a href="/pubmed/16439621" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16439621</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.sarkozy.2009.695">Sarkozy A, Carta C, Moretti S, Zampino G, Digilio MC, Pantaleoni F, Scioletti AP, Esposito G, Cordeddu V, Lepri F, Petrangeli V, Dentici ML, Mancini GM, Selicorni A, Rossi C, Mazzanti L, Marino B, Ferrero GB, Silengo MC, Memo L, Stanzial F, Faravelli F, Stuppia L, Puxeddu E, Gelb BD, Dallapiccola B, Tartaglia M. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:695–702.</span> [<a href="/pmc/articles/PMC4028130/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4028130</span></a>] [<a href="/pubmed/19206169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19206169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.sarkozy.2004.1069">Sarkozy A, Obregon MG, Conti E, Esposito G, Mingarelli R, Pizzuti A, Dallapiccola B. A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/LEOPARD syndrome and Noonan-like/multiple giant cell lesion syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2004;<span class="ref-vol">12</span>:1069–72.</span> [<a href="/pubmed/15470362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15470362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.sarkozy.2008.13">Sarkozy A, Digilio MC, Dallapiccola B. Leopard syndrome. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2008;<span class="ref-vol">3</span>:13.</span> [<a href="/pmc/articles/PMC2467408/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2467408</span></a>] [<a href="/pubmed/18505544" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18505544</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.smith.2005.879">Smith RJ, Bale JF Jr, White KR. Sensorineural hearing loss in children. <span><span class="ref-journal">Lancet. </span>2005;<span class="ref-vol">365</span>:879–90.</span> [<a href="/pubmed/15752533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15752533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.tartaglia.2004a.492">Tartaglia M, Cordeddu V, Chang H, Shaw A, Kalidas K, Crosby A, Patton MA, Sorcini M, van der Burgt I, Jeffery S, Gelb BD. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2004a;<span class="ref-vol">75</span>:492–7.</span> [<a href="/pmc/articles/PMC1182027/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182027</span></a>] [<a href="/pubmed/15248152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15248152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.tartaglia.2003a.423">Tartaglia M, Cotter PD, Zampino G, Gelb BD, Rauen KA. Exclusion of PTPN11 mutations in Costello syndrome: further evidence for distinct genetic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes. <span><span class="ref-journal">Clin Genet. </span>2003a;<span class="ref-vol">63</span>:423–6.</span> [<a href="/pubmed/12752577" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12752577</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.tartaglia.2004b.307">Tartaglia M, Martinelli S, Cazzaniga G, Cordeddu V, Iavarone I, Spinelli M, Palmi C, Carta C, Pession A, Arico M, Masera G, Basso G, Sorcini M, Gelb BD, Biondi A. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. <span><span class="ref-journal">Blood. </span>2004b;<span class="ref-vol">104</span>:307–13.</span> [<a href="/pubmed/14982869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14982869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.tartaglia.2006.279">Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt I, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">78</span>:279–90.</span> [<a href="/pmc/articles/PMC1380235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1380235</span></a>] [<a href="/pubmed/16358218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16358218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.tartaglia.2003b.148">Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. <span><span class="ref-journal">Nat Genet. </span>2003b;<span class="ref-vol">34</span>:148–50.</span> [<a href="/pubmed/12717436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12717436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.tr_ger.2003.82">Tr&#x000f6;ger B, Kutsche K, Bolz H, L&#x000fc;ttgen S, Gal A, Almassy Z, Caliebe A, Freisinger P, Hobbiebrunken E, Morlot M, Stefanova M, Streubel B, Wieczorek D, Meinecke P. No mutation in the gene for Noonan syndrome, PTPN11, in 18 patients with Costello syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">121A</span>:82–4.</span> [<a href="/pubmed/12900909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12900909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.voron.1976.447">Voron DA, Hatfield HH, Kalkhoff RK. Multiple lentigines syndrome. Case report and review of the literature. <span><span class="ref-journal">Am J Med. </span>1976;<span class="ref-vol">60</span>:447–56.</span> [<a href="/pubmed/1258892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1258892</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leopard.REF.witt.1986.150">Witt DR, Keena BA, Hall JG, Allanson JE. Growth curves for height in Noonan syndrome. <span><span class="ref-journal">Clin Genet. </span>1986;<span class="ref-vol">30</span>:150–3.</span> [<a href="/pubmed/3780030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3780030</span></a>]</div></li></ul></div></div><div id="leopard.Chapter_Notes"><h2 id="_leopard_Chapter_Notes_">Chapter Notes</h2><div id="leopard.Acknowledgments"><h3>Acknowledgments</h3><p>This work was supported in part by grants from: the National Institutes of Health (HL071207) to BDG; and Telethon-Italy (GGP13107), Associazione Italiana Ricerca sul Cancro (AIRC, IG13360) and Ministry of Health (RF-2011-02349938) to MT.</p></div><div id="leopard.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>14 May 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 November 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 November 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>13 November 2007 (bdg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1383</span><span class="label">PMID: <a href="/pubmed/20301557" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301557</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/noonan/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/leigh-nucl-ov/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1383&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1383/?report=reader">PubReader</a></li><li><a href="/books/NBK1383/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1383" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1383" style="display:none" title="Cite this Page"><div class="bk_tt">Gelb BD, Tartaglia M. Noonan Syndrome with Multiple Lentigines. 2007 Nov 30 [Updated 2015 May 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1383/pdf/Bookshelf_NBK1383.pdf">PDF version of this page</a> (237K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#leopard.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#leopard.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#leopard.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#leopard.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#leopard.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#leopard.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#leopard.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#leopard.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#leopard.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#leopard.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#leopard.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=673[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BRAF</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5894[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RAF1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5781[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PTPN11</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1383+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1484044" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1484044" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1484044" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1484044" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301303" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Noonan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Noonan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Allanson JE, Roberts AE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25423878" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines.</a><span class="source">[Am J Med Genet A. 2015]</span><div class="brieflinkpop offscreen_noflow">A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nishi E, Mizuno S, Nanjo Y, Niihori T, Fukushima Y, Matsubara Y, Aoki Y, Kosho T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2015 Feb; 167A(2):407-11. Epub 2014 Nov 25.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31145570" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wenger TL, Hing AV, Evans KN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301534" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moosajee M, Hingorani M, Moore AT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301557" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301557" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc909bdde08911694e4c04">Noonan Syndrome with Multiple Lentigines - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Noonan Syndrome with Multiple Lentigines - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:13:00-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D428CDFC8C20100000000022100F7&amp;ncbi_session=CE8D428CDFC909B1_0545SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1383%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1383&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1383/&amp;ncbi_pagename=Noonan Syndrome with Multiple Lentigines - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D428CDFC909B1_0545SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>